{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihahq4skk2sdiuvgnqdushboiy3bdnh3z3oekuydpgtaieeh5dumq",
    "uri": "at://did:plc:p3227y2hdjlcc64d55t4c5y4/app.bsky.feed.post/3mjxbij7alpp2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifat6dlg3x2v32eawdaowyzxrrx5z2ihcy32iuqdz3tfrrpitezii"
    },
    "mimeType": "image/jpeg",
    "size": 247673
  },
  "path": "/2026/04/20/the-promise-and-limits-of-trumps-psychedelic-therapy-order/",
  "publishedAt": "2026-04-20T19:40:13.000Z",
  "site": "https://reason.com",
  "tags": [
    "Addiction",
    "Drug Legalization",
    "Drug Policy",
    "MDMA",
    "Medicine",
    "Psychedelics",
    "War on Drugs",
    "Colorado",
    "Department of Health and Human Services",
    "Donald Trump",
    "FDA",
    "Joe Rogan",
    "Oregon",
    "Psilocybin",
    "Psychology/Psychiatry",
    "PTSD",
    "Regulation",
    "Research",
    "Suicide",
    "Trump Administration",
    "Veterans"
  ],
  "textContent": "President Donald Trump displays an executive order aimed at facilitating approval of psychedelic therapy",
  "title": "The Promise and Limits of Trump's Psychedelic Therapy Order"
}